Skip to content

Clinical trials

Completed Hematologic Neoplasms trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Neoplasms Status: Completed Country / region: Japan Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20091
20111
20121
20141
20171
20211
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
Novartis Pharmaceuticals2
AbbVie1
Amgen1
Janssen Pharmaceutical K.K.1
Keio University1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Neoplasms9
Leukemia, Myeloid, Acute3
Bone Marrow Diseases2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive2
Lymphoma, Large B-Cell, Diffuse2
Neoplasms2
Blood Protein Disorders1
Bone Diseases1
Bone Neoplasms1
Colorectal Neoplasms1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.